Mechanisms and environmental factors that underlying the intensification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced serotonin syndrome in rats

被引：0
|
作者：
Rui Tao
Ibrahim M. Shokry
John J. Callanan
H. Daniel Adams
Zhiyuan Ma
机构：
[1] Florida Atlantic University,Charles E. Schmidt College of Medicine
[2] Ross University,School of Veterinary Medicine
来源：
Psychopharmacology | 2015年 / 232卷
关键词：
MDMA; Serotonin syndrome; Neurotoxicity; 5-HT; receptors; 5-HT; receptors; Hyperthermia; Microdialysis; EEG;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1245 / 1260
页数：15
相关论文
共 50 条
  • [21] Morphological adaptations in the brain motive circuit induced by 3,4-methylenedioxymethamphetamine (MDMA; ecstasy)
    Ball, Kevin
    FASEB JOURNAL, 2010, 24
  • [22] Changes in gene expression induced by prenatal 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) exposure
    Lyles, J
    Cai, NS
    Cadet, JL
    FASEB JOURNAL, 2003, 17 (05): : A1213 - A1213
  • [23] Persistent loss of thermoregulation in the rat induced by 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy") but not by fenfluramine
    Dafters, RI
    Lynch, E
    PSYCHOPHARMACOLOGY, 1998, 138 (02) : 207 - 212
  • [24] Demographic and health characteristics of 3,4-methylenedioxymethamphetamine users (MDMA, ecstasy)
    Wieckiewicz, Gniewko
    Danel, Dariusz
    Piegza, Magdalena
    Gorczyca, Piotr
    Pudlo, Robert
    PSYCHIATRIA POLSKA, 2022, 56 (05) : 1109 - 1130
  • [25] Persistent loss of thermoregulation in the rat induced by 3,4-methylenedioxymethamphetamine (MDMA or “Ecstasy”) but not by fenfluramine
    R. I. Dafters
    Emily Lynch
    Psychopharmacology, 1998, 138 : 207 - 212
  • [26] 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA, 'ECSTASY'): GENDER DIFFERENCES IN PHARMACOKINETICS AND PHARMACODYNAMICS
    Pardo-Lozano, R.
    Farre, M.
    Yubero-Lahoz, S.
    Torrens, M.
    Mustata, C.
    Perez-Mana, C.
    Menoyo, E.
    Perez, M.
    Martin, S.
    Cuyas, E.
    Civit, E.
    O'Mathuna, B.
    Carbo, M.
    de la Torre, R.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 51 - 52
  • [27] Neuropsychiatric manifestations following the use of 3,4-methylenedioxymethamphetamine (MDMA; ''Ecstasy'')
    Cohen, RS
    Cocores, J
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1997, 21 (04): : 727 - 734
  • [28] Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users
    Back-Madruga, C
    Boone, KB
    Chang, L
    Grob, CS
    Lee, A
    Nations, H
    Poland, RE
    CLINICAL NEUROPSYCHOLOGIST, 2003, 17 (04) : 446 - 459
  • [29] PERSISTENT EFFECTS OF (+/-)3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA, ECSTASY) ON HUMAN SLEEP
    ALLEN, RP
    MCCANN, UD
    RICAURTE, GA
    SLEEP, 1993, 16 (06): : 560 - 564
  • [30] Language function in abstinent 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy") users
    Campbell, Z
    Zakzanis, KK
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2003, 18 (07) : 721 - 721
12345